Skip to main content

Connect and stay on top of the MedTech regulatory landscape globally.

Pure Global is a trusted global leader and growth partner in the healthcare technology industry. Find regulatory insights from our expert team, AI-powered regulatory news tools, and ways to meet us at upcoming events.

Join Our Community

What you get from signing up

Subscribe to our MedTech newsletter for regulatory insights, early resource access, and practical updates that help you stay ahead.

Regulatory Updates

Be informed on regulatory changes

Stay ahead of the curve with timely updates on the latest regulatory changes impacting the MedTech industry.

Upcoming Events

Find us at future MedTech events

Explore our participation in key conferences, summits, and networking opportunities through our upcoming events list.

Blog

Get insights from industry experts

Gain valuable perspectives from experienced MedTech professionals through our blog articles.

News

Regulatory News

Explore regulatory updates and industry insights designed to help you take your product global.

Hong Kong MDD’s GN-02 and GN-06 2026 (Ed. 1.0) listing notes are effective 31 July 2026. Applications already in MDIS are unaffected. The in-force texts cover Novo Lane, the default Expedited Approval Scheme, Hospital Authority purchase-order fields, and translation evidence.

Hong Kong MDD issued GN-10:2026(E) Edition 3, effective 26 June 2026. The change-management notes add clause 5.3: eighteen listed-device changes that do not require reporting, unless they follow a safety alert or could affect safety, quality, or performance. Major Changes still need approval before implementation.

ANVISA now requires Class I and II foreign manufacturer record requests, including IVDs, to use Solicita subject 80326. The record generates the unique international-manufacturer code required in imported-product filings; Class III and IV remain CBPF-linked.

HSA’s GN-21 Revision 7, labelled Revision 6.1 and effective 1 August 2026, ends implement-on-acknowledgement for 6Aii and 6Aiii public SMDR listing changes. Those changes now need HSA approval before implementation in Singapore. Annex 2 also caps each listing at two active change-notification applications, with full rejection and no fee refund if a third is filed.

News

Company News

Browse company milestones, strategic updates, and announcements from Pure Global.

Pure Global has launched a flat-fee pricing model for medical device registration that simplifies global expansion across 13 key markets. With AI-assisted dossier preparation and in-country representation included, manufacturers can easily plan their market access budgets.

Company News

Pure Global has launched AI Builder, a proprietary automation platform that cuts medical device dossier preparation time by up to 75%. The launch introduces a new flat annual pricing model and marks a major step toward on-demand, AI-powered global medical device registration.

Pure Global's new CTO, Ran Chen, brings over a decade of experience in building and scaling machine learning products.

Pure Global is proud to announce its inclusion in the China Business Service Providers (BSP) directory on the International Trade Administration website.

Blog

Recent Blog Posts

Read articles, success stories, and regulatory insights from our global market access experts.

Coronary Stent Global Market Access 2026: Class III Almost Everywhere

Coronary stents sit at the highest regulatory tier across major markets. This report maps four US regulatory objects, the PMA supplement lifecycle, eight market-access files, public register evidence, postmarket limits, government fees and a sequencing plan for manufacturers.

Surgical Robot Global Market Access 2026: One Platform, Eight Regulatory Files

Surgical robots do not follow one regulatory class or one reusable filing. This research report maps the public records across eight markets, showing how architecture drives FDA classification, why one platform becomes dozens of registration objects, where clinical evidence controls the schedule, and what government and in-country representation fees actually cost.

ISO 10993-1:2025 Global Transition Guide: How to Build One Biological Evaluation Plan for Seven Regulatory Systems

ISO 10993-1 changed in 2025, but regulators did not change together. This practical guide maps seven regulatory systems and shows how to build one controlled biological-evaluation core with market-specific overlays.

In Vitro Diagnostics Global Market Access 2026: The Year the Rules Moved in Opposite Directions

The EU inverted its IVD regime and the US reverted its own. This report rebuilds what that means for classification, timelines and cost from the registers themselves — including 238 IVDR certificates against 3,343 for devices, and the risk-class split across nine national registers.

Events

Events

Meet the Pure Global team at upcoming events and discuss your regulatory and market access questions.

Medical Fair Asia 2026 event logo
Trade Fair
Marina Bay Sands, Singapore
Sep 9, 2026

Medical Fair Asia

Medical Fair Asia 2026 is a leading healthcare trade exhibition in Singapore, connecting medical specialists, business executives, and industry professionals across hospital, diagnostic, pharmaceutical, medical equipment, and healthcare supply sectors.

Trade Fair
Charlotte, North Carolina, USA
Sep 15, 2026

RAPS USA Convergence

An event focusing on regulatory aspects, attracting professionals from around the world to discuss the latest trends and regulations.

Trade Fair
Düsseldorf, Germany
Nov 16, 2026

MEDICA Trade Fair

One of the largest medical B2B trade fairs globally, showcasing products and services across medical imaging, diagnostics, health IT, and more.

essential industry news delivered to your inbox

Thank you for subscribing!
Oops! Something went wrong while submitting the form.
By subscribing, you agree to our Terms of Use.

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Contact us